Skip to main content

MassBio Symposium

On Thursday, January 24, 2019, Dave Dykeman, shareholder and co-chair of Greenberg Traurig’s Life Sciences & Medical Technology Group, moderated the Massachusetts Biotechnology Council (MassBio) symposium panel entitled, “Building an IP Fence Around Your Drug Device Combination Product." The panel addressed how combination products today blend drugs, devices, and services to improve patient outcomes, and how device IP can add further value and protection.